Beranda › Kanker Darah › New York

Uji klinis Kanker Darah di New York

29 studi untuk Kanker Darah mencari peserta di lokasi di New York.

Kota di New York

Teks studi resmi (Bahasa Inggris)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0032), New York
White Plains Hospital-Center for Cancer Care ( Site 0069), White Plains

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT03486873

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Queens Hospital Center, Jamaica
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
Stony Brook University Medical Center, Stony Brook

Menerima pesertaStudi observasionalSukarelawan sehat diterima

Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

NYU Langone Health, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07572006

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

Mount Sinai Medical Center, New York
University of Rochester Medical Center, Rochester

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT04634552

Genomic Profiling in Cancer Patients

Kings County Hopsital Center, Brooklyn
Memorial Sloan Kettering Cancer Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
dan 7 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT01775072

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

Quetzal Site 4, Buffalo
Quetzal Site 2, The Bronx

Menerima pesertaFase 3

Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NYU Langone Hospital - Long Island, Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
dan 1 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

David H. Koch Center for Cancer Care, New York
Montefiore Medical Center PRIME, The Bronx

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07648264

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

Hematology Oncology Associates of Central New York-Auburn, Auburn
Roswell Park Cancer Institute, Buffalo
Hematology Oncology Associates of CNY at Camillus, Camillus
dan 5 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04242095

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07195916

A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies

Research Site, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT07220616

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

State University of New York at Buffalo, Buffalo
Icahn School of Medicine at Mount Sinai, New York
Columbia University, New York
dan 1 lainnya

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Roswell Park Comprehensive Cancer Center, Buffalo
Northwell Health, LLC PRIME, Lake Success
Memorial Sloan Kettering Cancer Center, New York
dan 3 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT06001788

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Northwell Health, Manhasset
NYP/Weill Cornell Medical Center, New York

Menerima pesertaSukarelawan sehat diterima

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04515810

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
dan 1 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Weill Cornell Medicine - New York Presbyterian Hospital, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Roswell Park Cancer Institute, Buffalo
North Shore University Hospital, Lake Sucess
Cohen Children's Medical Center of New York, New Hyde
dan 9 lainnya

Menerima pesertaStudi observasional

Semua usia · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT01351545

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
New York University (Data Collection Only), New York
dan 2 lainnya

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT07006506

IVIG for Infection Prevention After CAR-T-Cell Therapy

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT05952804

An Extension Study for Patients Previously Enrolled in Studies With Pelabresib

New York Presbyterian Hospital, New York
Mt Sinai Medical Center, New York

Menerima pesertaFase 3

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06401356

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Mount Sinai Hospital, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05663502

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center (All protocol activities), New York
dan 1 lainnya

Menerima pesertaSukarelawan sehat diterima

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT07052916

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Roswell Park Comprehensive Cancer Center, Buffalo
Mt Sinai, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1/2

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT03328078

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Roswell Park Comprehensive Cancer Center, Buffalo
New York - Presbyterian / Weill Cornell Medicine, New York
Mount Sinai - Ruttenberg Treatment Center, New York
dan 2 lainnya

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT05735184

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaStudi observasional

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT07362225

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2025 · NCT06462365

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Children's Hospital New York-Presbyterian, New York
Memorial Sloan Kettering Cancer Center, New York

Menerima pesertaFase 1

Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Des 2024 · NCT05476770

Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT

Memorial Sloan Kettering Cancer Center (MSKCC), New York

Menerima pesertaFase 1/2

Semua usia · Semua jenis kelamin · Diperbarui 6 Mar 2023 · NCT04959903

The Leukemia and Lymphoma Society (LLS) National Research Registry

Lymphoma and Leukemia Society, Rye Brook

Menerima pesertaStudi observasional

Usia 21 ke atas · Semua jenis kelamin · Diperbarui 7 Apr 2022 · NCT04806295

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.